DUBLIN--(BUSINESS WIRE)--May. 21, 2012--
(NYSE: COV), a leading global provider of healthcare products, today
announced the appointment of Gregory S. Andrulonis as Vice President and
Treasurer, effective immediately.
Mr. Andrulonis succeeds Kevin G. DaSilva in this role. Mr. DaSilva will
remain Vice President, Group Chief Financial Officer, responsible for
finance activities in Covidien’s Respiratory & Monitoring Solutions and
Vascular Therapies global business units, as well the Company’s
businesses in Japan, Australia-New Zealand and Canada, a position he has
held since July 2011. Mr. DaSilva served as treasurer of the Company
since June 2007, when Covidien separated from Tyco International and
became an independent company.
Mr. Andrulonis previously served as Vice President and Assistant
Treasurer, Capital Planning and Markets, responsible for all aspects of
Covidien's capital markets, capital planning and credit functions. This
included equity and debt financing activities in the financial markets,
capital planning and structure, interest rate and foreign exchange rate
risk management, global credit and collections and retirement plan
investments. He held this position since it was created in June 2007.
Prior to the separation, Mr. Andrulonis was the Director of Capital
Markets for Tyco International. Prior to joining Tyco, he worked at
Lucent Technologies as Regional Treasurer for Latin America, and he held
several positions of increasing responsibility in treasury, credit and
banking earlier in his career.
Mr. Andrulonis holds a bachelor’s degree from La Salle University and a
master’s degree in finance from Temple University. Both universities are
located in Philadelphia, Pennsylvania.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien manufactures,
distributes and services a diverse range of industry-leading product
lines in three segments: Medical Devices, Pharmaceuticals and Medical
Supplies. With 2011 revenue of $11.6 billion, Covidien has 41,000
employees worldwide in more than 65 countries, and its products are sold
in over 140 countries. Please visit www.covidien.com
to learn more about our business.
Eric Kraus, 508-261-8305
Senior Vice President
Lannum, CFA, 508-452-4343